Identification of a CTL4/Neu1 Fusion Transcript in a Sialidosis Patient
Overview
Affiliations
The deficiency of the lysosomal neuraminidase (NEU1; sialidase) causes the storage disorder sialidosis with symptoms ranging from eye abnormalities and neurological disturbances to skeletal malformations, mental retardation and early death. Sialidosis patients encompassing a wide spectrum of clinical symptoms were screened for mutations in neu1. We identified the same homozygous interstitial deletion (11 kb) in two patients causing the fusion of exon 10 of CTL4 (New Gene 22; NG22) with the 3'-UTR of neu1. In one patient we found the resulting CTL4/Neu1 fusion transcript, in the other we detected an alternatively spliced CTL4 transcript (retention of intron 9).
Cao Y, Zhang J, Wang J Mol Neurobiol. 2024; .
PMID: 39565569 DOI: 10.1007/s12035-024-04612-8.
NEU1-A Unique Therapeutic Target for Alzheimer's Disease.
Khan A, Sergi C Front Pharmacol. 2022; 13:902259.
PMID: 35847014 PMC: 9277458. DOI: 10.3389/fphar.2022.902259.
Therapeutic Potential of Neu1 in Alzheimer's Disease Via the Immune System.
Khan A, Das S, Sergi C Am J Alzheimers Dis Other Demen. 2021; 36:1533317521996147.
PMID: 33719595 PMC: 10624071. DOI: 10.1177/1533317521996147.
Mitsiakos G, Gialamprinou D, Chouchou P, Chatziioannidis I, Karagianni P Hippokratia. 2020; 23(4):169-171.
PMID: 32742167 PMC: 7377589.
The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.
Orsini A, Valetto A, Bertini V, Esposito M, Carli N, Minassian B Seizure. 2019; 71:247-257.
PMID: 31476531 PMC: 7288863. DOI: 10.1016/j.seizure.2019.08.012.